Effect of dietary eicosapentaenoic acid on plasma lipids and platelet function in stroke-prone spontaneously hypertensive rat
- PMID: 2210963
Effect of dietary eicosapentaenoic acid on plasma lipids and platelet function in stroke-prone spontaneously hypertensive rat
Abstract
An investigation was undertaken to study the effect of EPA in rats fed different protein sources. A highly concentrated EPA (78% EPA, ethyl ester form), manufactured from sardine oil was administered to SHRSP (Stroke-prone spontaneously hypertensive rat) and WKY (Wistar Kyoto) for 4 weeks. Casein or SPI (soy protein isolate) was used as protein source in the experimental diet. In the experiment concerning casein diet, showing significant decrease in systolic blood pressure, plasma lipids of SHRSP were observed after EPA treatment, but no significant difference was found in SPI diet group. Although there was no significant change in systolic blood pressure of WKY after EPA treatment, a similar effect of EPA on plasma lipids level and platelet aggregation were also observed in WKY. However, supplementing methionine to SPI diet induced the reducing effect of EPA in rats. In addition, higher level ratios of EPA to arachidonic acid were observed in the plasma and platelets of rats fed SPI diet containing methionine supplement when compared with rats fed SPI diet. It was suggested that the amino acid profile was related to the effective utilization of EPA in rats.
Similar articles
-
Effect of dietary protein on the peroxidation of eicosapentaenoic acid in stroke-prone spontaneously hypertensive rats.Int J Vitam Nutr Res. 1991;61(3):239-43. Int J Vitam Nutr Res. 1991. PMID: 1794953
-
Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval QT in spontaneously hypertensive rats in vivo.Prostaglandins Leukot Essent Fatty Acids. 2009 May-Jun;80(5-6):269-77. doi: 10.1016/j.plefa.2009.03.003. Epub 2009 May 9. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19428232
-
Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.J Hum Hypertens. 1996 Sep;10 Suppl 3:S135-9. J Hum Hypertens. 1996. PMID: 8872845 Clinical Trial.
-
Acute and chronic effects of eicosapentaenoic acid (EPA) on the cardiovascular system.Res Commun Chem Pathol Pharmacol. 1989 Dec;66(3):355-74. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2558405
-
Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.Metabolism. 2006 Mar;55(3):381-90. doi: 10.1016/j.metabol.2005.09.013. Metabolism. 2006. PMID: 16483883
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials